Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H16ClNO4 |
| Molecular Weight | 309.745 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(COC(C)(C)C(O)=O)OC(=N1)C2=CC=C(Cl)C=C2
InChI
InChIKey=LNXXSBRGLBOASF-UHFFFAOYSA-N
InChI=1S/C15H16ClNO4/c1-9-12(8-20-15(2,3)14(18)19)21-13(17-9)10-4-6-11(16)7-5-10/h4-7H,8H2,1-3H3,(H,18,19)
Romazarit, (Ro 31-3948, 7), 2-[[2-(4-chlorophenyl)-4-methyl-5-oxazolyl]methoxy]-2-methylpropionic acid is a substituted heterocyclic alkoxypropionic acid. Romazarit was considered to be a potential disease-modifying antirheumatic drug. Romazarit was withdrawn due to its toxicity profile.
Originator
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
144 mg/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/2088768 |
1500 mg single, oral dose: 1500 mg route of administration: Oral experiment type: SINGLE co-administered: |
ROMAZARIT plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
958 mg × h/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/2088768 |
1500 mg single, oral dose: 1500 mg route of administration: Oral experiment type: SINGLE co-administered: |
ROMAZARIT plasma | Homo sapiens population: HEALTHY age: ADULT sex: MALE food status: FASTED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis of 4-benzyl-1,3-thiazole derivatives as potential anti-inflammatory agents: an analogue-based drug design approach. | 2009-06 |
|
| Tetra substituted thiophenes as anti-inflammatory agents: exploitation of analogue-based drug design. | 2005-12-15 |
|
| Population pharmacodynamics of romazarit. | 1995-03 |
|
| A pharmacokinetic and tolerance study of romazarit in patients with rheumatoid arthritis. | 1992-03 |
|
| Romazarit: a potential disease-modifying antirheumatic drug. | 1991-02 |
|
| Pharmacokinetics and tolerance of romazarit after oral administration of ascending single doses to healthy human volunteers. | 1990-10-01 |
|
| Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug. | 1990-03 |
Patents
Sample Use Guides
patients with rheumatoid arthritis:
200 mg or 450 mg every 12 h for up to 24 weeks,
100 mg t.i.d., 350 mg b.i.d., or 350 mg t.i.d., for 6 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2156999
In vitro romazarit was an extremely weak inhibitor of prostaglandin synthetase activity in both sheep seminal vesicle (IC50 6500 microM) and rat renal medulla (IC50 greater than 300 microM) cell-free preparations.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29634
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C063528
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
CC-90
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
CN68E94R2X
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
C73094
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
SUB10371MIG
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
71321
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
DTXSID6046216
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
100000084354
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL165090
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
6393
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY | |||
|
109543-76-2
Created by
admin on Mon Mar 31 18:31:07 GMT 2025 , Edited by admin on Mon Mar 31 18:31:07 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)